CN1956711B - 过氧化物酶体增殖物激活受体（ppar）活化剂以及使用了该活化剂的药品、补充剂、功能性食品及食品添加剂 - Google Patents

过氧化物酶体增殖物激活受体（ppar）活化剂以及使用了该活化剂的药品、补充剂、功能性食品及食品添加剂 Download PDF

Info

Publication number
CN1956711B
CN1956711B CN2005800160315A CN200580016031A CN1956711B CN 1956711 B CN1956711 B CN 1956711B CN 2005800160315 A CN2005800160315 A CN 2005800160315A CN 200580016031 A CN200580016031 A CN 200580016031A CN 1956711 B CN1956711 B CN 1956711B
Authority
CN
China
Prior art keywords
cryptoxanthin
ppar
activators
citrus
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN2005800160315A
Other languages
English (en)
Chinese (zh)
Other versions
CN1956711A (zh
Inventor
佐佐木贵生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arkray Inc
Original Assignee
Arkray Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arkray Inc filed Critical Arkray Inc
Publication of CN1956711A publication Critical patent/CN1956711A/zh
Application granted granted Critical
Publication of CN1956711B publication Critical patent/CN1956711B/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Medical Informatics (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
CN2005800160315A 2004-05-20 2005-05-20 过氧化物酶体增殖物激活受体（ppar）活化剂以及使用了该活化剂的药品、补充剂、功能性食品及食品添加剂 Expired - Lifetime CN1956711B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP150667/2004 2004-05-20
JP2004150667 2004-05-20
JP242653/2004 2004-08-23
JP2004242653 2004-08-23
PCT/JP2005/009258 WO2005112904A1 (ja) 2004-05-20 2005-05-20 ペルオキシソーム増殖剤応答性受容体（ppar）活性化剤、ならびにそれを用いた医薬、サプリメント、機能性食品および食品添加物

Publications (2)

Publication Number Publication Date
CN1956711A CN1956711A (zh) 2007-05-02
CN1956711B true CN1956711B (zh) 2010-06-09

Family

ID=35428235

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800160315A Expired - Lifetime CN1956711B (zh) 2004-05-20 2005-05-20 过氧化物酶体增殖物激活受体（ppar）活化剂以及使用了该活化剂的药品、补充剂、功能性食品及食品添加剂

Country Status (5)

Country Link
US (1) US20070218147A1 (enExample)
EP (1) EP1772143A4 (enExample)
JP (3) JPWO2005112904A1 (enExample)
CN (1) CN1956711B (enExample)
WO (1) WO2005112904A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007223914A (ja) * 2006-02-21 2007-09-06 Unitika Ltd 経口投与組成物
JP2007223979A (ja) * 2006-02-24 2007-09-06 Ehime Inryo:Kk 肝臓脂質蓄積抑制剤
JP5099617B2 (ja) * 2006-03-16 2012-12-19 国立大学法人東京農工大学 歯周病予防・治療剤
JP2008297216A (ja) * 2007-05-29 2008-12-11 Unitika Ltd 繊維芽細胞増殖促進剤
JP5356667B2 (ja) * 2007-09-28 2013-12-04 ユニチカ株式会社 体内時計正常化効果を有する組成物
JP5577019B2 (ja) * 2007-12-28 2014-08-20 ユニチカ株式会社 経口投与組成物
JP5830214B2 (ja) * 2008-02-01 2015-12-09 株式会社ダイセル 経口投与組成物
US20100273727A1 (en) * 2007-12-28 2010-10-28 Unitika Ltd. Oral administration composition
JP2010202553A (ja) * 2009-03-02 2010-09-16 Unitika Ltd レチノイン酸受容体（ｒａｒ）活性化剤
JP2010254592A (ja) * 2009-04-22 2010-11-11 Ito En Ltd 脂肪蓄積抑制剤及びそれを含有する飲食品
JP5909084B2 (ja) 2010-12-15 2016-04-26 アークレイ株式会社 安定化βクリプトキサンチン含有水およびその用途
JP2012206964A (ja) * 2011-03-29 2012-10-25 Unitika Ltd ＰＰＡＲ−α活性調節剤
CN103110846B (zh) 2013-02-22 2014-07-02 嵊州市林美生物科技有限公司 一种用于治疗高脂血症的中药组合物及其制备方法和应用
JP5925751B2 (ja) * 2013-12-03 2016-05-25 株式会社ダイセル 経口投与組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1355695A (zh) * 1999-04-14 2002-06-26 利库德天然产品工业有限公司 用于降低血液中的胰岛素样生长因子－i(igf－i)的化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5215660B2 (enExample) * 1974-05-10 1977-05-02
JPH06165651A (ja) 1991-02-01 1994-06-14 Koopu Foods:Kk 蜜柑麺の製造方法
JP3359298B2 (ja) * 1998-05-06 2002-12-24 株式会社愛媛柑橘資源開発研究所 かんきつ果汁由来のカロチノイド高含有粉末の製造方法
JP2000093086A (ja) 1998-09-18 2000-04-04 Haato & Haato:Kk 蜜柑入り外郎及びその製造方法
TR200103002T2 (tr) * 1999-03-11 2002-03-21 Nuclear Receptor Research Limited PPAR nkleer resept”rleri i‡in yeni ligandlar
CA2407421C (en) * 2000-04-24 2009-11-03 Nikken Chemicals Co., Ltd. Activators of peroxisome proliferator-activated receptors
JP2004194512A (ja) * 2002-12-16 2004-07-15 Aritagawa:Kk ミカン粉末、このミカン粉末を用いた餅菓子
JP2004331528A (ja) * 2003-05-02 2004-11-25 Toyo Seikan Kaisha Ltd 柿の果実からβ−クリプトキサンチン成分含有抽出物を製造する方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1355695A (zh) * 1999-04-14 2002-06-26 利库德天然产品工业有限公司 用于降低血液中的胰岛素样生长因子－i(igf－i)的化合物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MONTONEN J. ET AL..Dietary antioxidant intake and risk of type 2 diabetes..DIABETES CARE.27 2.2004,27(2),362 - 366.
MONTONEN J. ET AL..Dietary antioxidant intake and risk of type 2 diabetes..DIABETES CARE.27 2.2004,27(2),362- 366. *
TAKAHASHI N. ET AL.Dual action of isoprenols from herbalmedicinesonboth PPARY an PPARx in 3T3-L1 adipocytesand HepG2hepatocytes.FEBS LETTERS.514 3.2002,514(3),315-322.
TAKAHASHI N. ET AL.Dual action of isoprenols from herbalmedicinesonboth PPARY an PPARx in 3T3-L1 adipocytesand HepG2hepatocytes.FEBS LETTERS.514 3.2002,514(3),315-322. *

Also Published As

Publication number Publication date
CN1956711A (zh) 2007-05-02
US20070218147A1 (en) 2007-09-20
JP2012214488A (ja) 2012-11-08
JP2014122247A (ja) 2014-07-03
WO2005112904A1 (ja) 2005-12-01
EP1772143A4 (en) 2009-12-30
EP1772143A1 (en) 2007-04-11
JPWO2005112904A1 (ja) 2008-03-27

Similar Documents

Publication Publication Date Title
JP2012214488A (ja) ペルオキシソーム増殖剤応答性受容体（ｐｐａｒ）活性化剤、ならびにそれを用いた医薬、サプリメント、機能性食品および食品添加物
JP5473191B2 (ja) ペルオキシソーム増殖剤応答性受容体（ｐｐａｒ）活性化剤、ならびにそれを用いた医薬、サプリメント、機能性食品および食品添加物
CN101491296A (zh) 一种天然饲料添加剂及其制备方法
JP6189595B2 (ja) 低アディポネクチン血症治療剤
JP2011148748A (ja) アディポネクチン分泌促進組成物
JP7185990B2 (ja) アディポネクチン分泌促進剤、脂肪前駆細胞分化促進剤並びにそれらを含む医薬組成物、食品及び飼料
KR101851639B1 (ko) 모과 추출물 또는 이의 분획물을 유효성분으로 함유하는 항비만용 조성물
JP2014185088A (ja) 経口組成物、脂肪細胞分化抑制剤および飲食品
US11260098B2 (en) Method for suppressing obesity or development of obesity
KR102208654B1 (ko) Tph1 유전자, ddc 유전자 및/또는 aanat 유전자의 발현을 조절하기 위한 바나나 껍질 추출물을 포함하는 조성물
JP4751066B2 (ja) 治療剤
KR20160149664A (ko) 보스웰리아 세라타 추출물, 포도씨 추출물 및 주니퍼베리 추출물을 유효성분으로 함유하는 관절염의 예방, 개선 또는 치료용 조성물
KR101637344B1 (ko) 삼채뿌리 추출물을 유효성분으로 포함하는 골 성장 촉진용 조성물
KR102738712B1 (ko) 미르시아페논 에이를 이용한 항고지혈증 또는 항비만용 조성물
JP2008161077A (ja) 血液流動性改善作用をもたらす機能性食品
JP7505728B2 (ja) 経口組成物
KR101830567B1 (ko) 트란스-네로리돌을 이용한 항고지혈증 또는 항비만용 조성물
JP2017222715A (ja) 経口組成物、脂肪細胞分化抑制剤および飲食品
JP2012153625A (ja) 糖尿病予防・治療剤
JP2009286729A (ja) アディポネクチン産生促進剤
JP2007008883A (ja) 血糖値低下作用を有する組成物
JP2007151537A (ja) 小豆の廃液から得られる有用材料、この有用材料の製造方法、この有用材料を含む食品及び薬剤
JP2007320947A (ja) 血糖値上昇抑制剤
KR20150091771A (ko) 바다포도 추출물을 포함하는 당뇨병 치료 또는 예방용 조성물
JP2010270069A (ja) モロヘイヤ抽出物を有効成分とする血管病治療予防剤、及びこれを含有する飲食品

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20100609